Tirzepatide Pen – 20 mg

Dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist providing enhanced appetite suppression, weight loss, and glycaemic control compared to GLP-1 agonists alone.

Activates both GLP-1 and GIP receptors to improve insulin sensitivity, slow gastric emptying, and regulate energy balance.

Strength: 8.33 mg/mL (20 mg per cartridge)
Volume: 2.4 mL
Dosage Form: Subcutaneous injection (disposable)

Medical Requirement: Baseline blood tests are necessary prior to prescribing. Simply share your recent results with us or request a blood test from our CeleRevive doctor.

Note: All products available through the CeleRevive platform are of high purity and are sourced from GMP-compliant manufacturing facilities. All injectables are >98-99% purity. Products are imported and distributed by fully licensed wholesale pharmacies, compounded and dispensed by fully licensed, compliant compounding pharmacies, and supplied only upon prescription by our licensed medical practitioner.

Regulatory Status: Tirzepatide is classified as a Registered and Established Medicine in South Africa. While commercial registered versions exist, the compounded formulations supplied are prepared on a patient-specific basis where clinically appropriate. Note that compounded versions for weight management are subject to strict regulatory oversight.